vs

Side-by-side financial comparison of Coeptis Therapeutics Holdings, Inc. (COEP) and Professional Diversity Network, Inc. (IPDN). Click either name above to swap in a different company.

Professional Diversity Network, Inc. is the larger business by last-quarter revenue ($1.7M vs $862.0K, roughly 1.9× Coeptis Therapeutics Holdings, Inc.). Coeptis Therapeutics Holdings, Inc. runs the higher net margin — -146.5% vs -173.5%, a 27.0% gap on every dollar of revenue.

Coeptis Therapeutics Holdings, Inc. is a clinical-stage biopharmaceutical company focused on developing innovative cancer immunotherapies, including cell therapy and antibody-based treatment candidates, to address unmet medical needs for patients with hard-to-treat malignancies. It primarily operates in the U.S., advancing its product pipeline across multiple oncology segments.

Professional Diversity Network, Inc. is a U.S.-based firm offering end-to-end diversity, equity and inclusion (DEI) solutions for corporate clients. Its services include targeted recruitment support for underrepresented talent groups, customized DEI training programs, and diversity performance data analytics, serving clients across tech, healthcare, finance and other core commercial sectors nationwide.

COEP vs IPDN — Head-to-Head

Bigger by revenue
IPDN
IPDN
1.9× larger
IPDN
$1.7M
$862.0K
COEP
Higher net margin
COEP
COEP
27.0% more per $
COEP
-146.5%
-173.5%
IPDN

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
COEP
COEP
IPDN
IPDN
Revenue
$862.0K
$1.7M
Net Profit
$-1.3M
$-2.9M
Gross Margin
94.8%
33.7%
Operating Margin
-230.6%
-173.2%
Net Margin
-146.5%
-173.5%
Revenue YoY
3.1%
Net Profit YoY
55.1%
-280.0%
EPS (diluted)
$0.05

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
COEP
COEP
IPDN
IPDN
Q4 25
$862.0K
$1.7M
Q3 25
$237.4K
$1.7M
Q2 25
$200.7K
$1.6M
Q1 25
$62.9K
$1.5M
Q4 24
$0
$1.6M
Q3 24
$0
$1.7M
Q2 24
$0
$1.7M
Q1 24
$0
$1.7M
Net Profit
COEP
COEP
IPDN
IPDN
Q4 25
$-1.3M
$-2.9M
Q3 25
$-2.9M
$-2.4M
Q2 25
$-4.3M
$-476.0K
Q1 25
$-3.4M
$-722.1K
Q4 24
$-2.8M
$-761.9K
Q3 24
$-1.8M
$-405.0K
Q2 24
$-3.0M
$-553.1K
Q1 24
$-3.0M
$-791.8K
Gross Margin
COEP
COEP
IPDN
IPDN
Q4 25
94.8%
33.7%
Q3 25
81.0%
44.0%
Q2 25
77.5%
43.4%
Q1 25
28.2%
52.2%
Q4 24
58.6%
Q3 24
58.9%
Q2 24
62.9%
Q1 24
62.2%
Operating Margin
COEP
COEP
IPDN
IPDN
Q4 25
-230.6%
-173.2%
Q3 25
-1043.2%
-136.3%
Q2 25
-2252.9%
-30.2%
Q1 25
-6452.6%
-46.9%
Q4 24
-36.8%
Q3 24
-25.0%
Q2 24
-34.4%
Q1 24
-46.5%
Net Margin
COEP
COEP
IPDN
IPDN
Q4 25
-146.5%
-173.5%
Q3 25
-1220.8%
-136.2%
Q2 25
-2159.9%
-29.0%
Q1 25
-5440.9%
-48.0%
Q4 24
-47.1%
Q3 24
-23.9%
Q2 24
-32.7%
Q1 24
-45.9%
EPS (diluted)
COEP
COEP
IPDN
IPDN
Q4 25
$0.05
Q3 25
$-0.58
Q2 25
$-1.17
Q1 25
$-1.11
Q4 24
$-5.35
Q3 24
$-0.05
Q2 24
$-0.08
Q1 24
$-0.08

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
COEP
COEP
IPDN
IPDN
Cash + ST InvestmentsLiquidity on hand
$676.6K
$217.0K
Total DebtLower is stronger
$150.0K
Stockholders' EquityBook value
$13.6M
$11.7M
Total Assets
$16.2M
$17.9M
Debt / EquityLower = less leverage
0.01×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
COEP
COEP
IPDN
IPDN
Q4 25
$676.6K
$217.0K
Q3 25
$421.7K
$265.3K
Q2 25
$990.6K
$125.1K
Q1 25
$496.4K
Q4 24
$1.7M
Q3 24
$133.7K
Q2 24
$619.3K
Q1 24
$97.1K
Total Debt
COEP
COEP
IPDN
IPDN
Q4 25
$150.0K
Q3 25
$150.0K
Q2 25
$150.0K
Q1 25
Q4 24
$150.0K
Q3 24
$1.7M
Q2 24
$1.7M
Q1 24
$2.3M
Stockholders' Equity
COEP
COEP
IPDN
IPDN
Q4 25
$13.6M
$11.7M
Q3 25
$10.4M
$8.9M
Q2 25
$6.1M
$4.5M
Q1 25
$6.5M
$4.9M
Q4 24
$3.4M
$5.3M
Q3 24
$4.8M
$2.1M
Q2 24
$-442.6K
$2.5M
Q1 24
$-1.1M
$2.3M
Total Assets
COEP
COEP
IPDN
IPDN
Q4 25
$16.2M
$17.9M
Q3 25
$14.2M
$12.1M
Q2 25
$12.2M
$7.3M
Q1 25
$13.5M
$7.7M
Q4 24
$8.9M
$8.0M
Q3 24
$9.0M
$5.3M
Q2 24
$4.2M
$5.8M
Q1 24
$3.9M
$5.7M
Debt / Equity
COEP
COEP
IPDN
IPDN
Q4 25
0.01×
Q3 25
0.01×
Q2 25
0.02×
Q1 25
Q4 24
0.04×
Q3 24
0.35×
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
COEP
COEP
IPDN
IPDN
Operating Cash FlowLast quarter
$-8.6M
$1.4M
Free Cash FlowOCF − Capex
$1.4M
FCF MarginFCF / Revenue
84.4%
Capex IntensityCapex / Revenue
0.0%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
COEP
COEP
IPDN
IPDN
Q4 25
$-8.6M
$1.4M
Q3 25
$-2.2M
$-2.7M
Q2 25
$-2.4M
$-495.5K
Q1 25
$-2.4M
$-284.1K
Q4 24
$-6.6M
$-1.2M
Q3 24
$-1.9M
$-556.9K
Q2 24
$-1.4M
$-224.4K
Q1 24
$-1.9M
$-543.1K
Free Cash Flow
COEP
COEP
IPDN
IPDN
Q4 25
$1.4M
Q3 25
$-2.7M
Q2 25
$-499.5K
Q1 25
Q4 24
$-1.2M
Q3 24
$-558.9K
Q2 24
$-225.9K
Q1 24
$-543.6K
FCF Margin
COEP
COEP
IPDN
IPDN
Q4 25
84.4%
Q3 25
-156.8%
Q2 25
-30.4%
Q1 25
Q4 24
-74.0%
Q3 24
-33.0%
Q2 24
-13.4%
Q1 24
-31.5%
Capex Intensity
COEP
COEP
IPDN
IPDN
Q4 25
0.0%
Q3 25
0.0%
Q2 25
0.2%
Q1 25
0.0%
Q4 24
1.3%
Q3 24
0.1%
Q2 24
0.1%
Q1 24
0.0%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons